Ablation of B7-H3 but Not B7-H4 Results in Highly Increased Tumor Burden in a Murine Model of Spontaneous Prostate Cancer
- 1 August 2015
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 3 (8) , 849-854
Abstract
The costimulatory molecules B7-H3 and B7-H4 are overexpressed in a variety of human tumors and have been hypothesized as possible biomarkers and immunotherapeutic targets. Despite this potential, the predominating uncertainty about their functional implication in tumor–host interaction hampers their evaluation as a target for cancer therapy. By means of a highly physiologic, spontaneous tumor model in mice, we establish a causal link between B7-H3 and host tumor control and found B7-H4 to be redundant. Cancer Immunol Res; 3(8); 849–54. ©2015 AACR.Keywords
All Related Versions
This publication has 18 references indexed in Scilit:
- Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cellsBritish Journal of Cancer, 2014
- Regulatory T cells in cancer immunotherapyCurrent Opinion in Immunology, 2014
- Animal Models of Human Prostate Cancer: The Consensus Report of the New York Meeting of the Mouse Models of Human Cancers Consortium Prostate Pathology CommitteeCancer Research, 2013
- B7‐H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis‐associated genesInternational Journal of Cancer, 2011
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonistsClinical and Experimental Immunology, 2009
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalNature Medicine, 2004
- Molecular Characterization of Human 4Ig-B7-H3, a Member of the B7 Family with Four Ig-Like DomainsThe Journal of Immunology, 2004
- Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent miceProceedings of the National Academy of Sciences, 1998
- Prostate cancer in a transgenic mouse.Proceedings of the National Academy of Sciences, 1995